N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide
C31H41N5O2 — CID 139993460
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide
N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide (PubChem CID 139993460) has the molecular formula C31H41N5O2 and a molecular weight of 515.70 g/mol. Its IUPAC name is N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide.
Molecular Properties
| Compound Name | N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide |
|---|---|
| PubChem CID | 139993460 |
| Molecular Formula | C31H41N5O2 |
| Molecular Weight | 515.70 g/mol |
| Exact Mass | 515.33 |
| IUPAC Name | N-[(1S)-3-[4-(3-benzyl-5-methyl-1,2,4-triazol-1-yl)piperidin-1-yl]-1-phenylpropyl]-2-(oxan-4-yl)acetamide |
| SMILES | Cc1nc(Cc2ccccc2)nn1C1CCN(CC[C@H](NC(=O)CC2CCOCC2)c2ccccc2)CC1 |
| InChI | InChI=1S/C31H41N5O2/c1-24-32-30(22-25-8-4-2-5-9-25)34-36(24)28-12-17-35(18-13-28)19-14-29(27-10-6-3-7-11-27)33-31(37)23-26-15-20-38-21-16-26/h2-11,26,28-29H,12-23H2,1H3,(H,33,37)/t29-/m0/s1 |
| InChIKey | PWRAMNSAYJZKNE-LJAQVGFWSA-N |
| XLogP | 4.88 |
| TPSA | 72.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 515.70 |
| LogP ≤ 5 | 4.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139993460 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.